We treat the whole range of urological conditions and employ the latest proven techniques using the most up-to-date technology to provide timely and low-risk care for our patients.
.png "Urology Partners is dedicated to providing all our patients with expert advice, patient choice and the very highest quality of clinical care.")
Practising from London, Surrey, Hampshire and Berkshire, Urology Partners are a group of expert consultant urologists who offer a tailor made approach to your treatment, ensuring you get the best treatment for you and your condition. Our focus on minimally invasive procedures means short hospital stays and rapid return to normal activity. We treat the whole range of Urological Conditions for both men and women.
Professor Richard Hindley talks to Dr Francesca Kum about Rezum treatment for BPH, including the results of clinical trials and the patient experience since starting in 2017.
Andrew Chetwood discusses Urethral Strictures and the Optilume treatment now available
Urology Partners offer the complete portfolio of treatments for minimally invasive surgery to treat Benign Prostatic Hyperplasia (BPH)
We are proud to report on the outstanding contribution from our consultant surgeons at the European Association of Urology (EAU) Annual Congress, held in March 2026—one of the most influential global gatherings in urological innovation, research, and clinical practice.
This year’s congress showcased not only the latest advances in urology but also the expertise and leadership of our team on the international stage. Recognition, live surgical demonstration, and academic presentation underscored our ongoing commitment to improving patient outcomes through evidence‑based, minimally invasive care.
A major highlight of the congress was Mr Neil Barber receiving the Patient Impact Award from Procept Biorobotics. This prestigious award recognises clinicians whose work has made a tangible and lasting difference to patients’ lives.
Neil’s dedication to advancing surgical techniques, specifically with Aquablation therapy, improving patient pathways, and championing outcomes that matter most to patients has been instrumental in shaping modern benign prostatic hyperplasia/obstruction (BPH/BPO) care. This award is a testament not only to his clinical excellence but also to his unwavering focus on patient‑centred innovation.
The recognition by Procept Biorobotics places Neil among a select group of clinicians whose work is influencing the future direction of therapeutic care worldwide.
Further demonstrating the expertise within our team, Mr Amr Emara was invited to perform a live GreenLight™ laser prostate surgery during the congress, broadcast directly from Guy’s Hospital to an international audience of urologists.
Live surgery sessions are among the most technically demanding elements of the EAU programme, requiring exceptional surgical precision, confidence, and the ability to articulate decision‑making in real time. Amr’s live demonstration highlighted the benefits of GreenLight laser technology, including its minimally invasive approach, reduced bleeding risk, and rapid patient recovery.
 |
 |
 |
The session provided valuable insight for delegates seeking to integrate or refine laser therapies within their own clinical practice and reinforced our centre’s role as a leader in advanced endoscopic prostate surgery.
Completing a strong showing from our consultants, Mr Richard Hindley delivered an invited presentation titled:
“A Decade of Evidence and Clinical Experience: Where Do We Advance With Minimally Invasive Therapy for BPO?”
Drawing on twenty years of accumulated data and real‑world outcomes, Richard explored how minimally invasive treatments have evolved, where they have succeeded, and the challenges that remain. His talk addressed the balance between innovation, durability of results, and patient selection—key considerations as new technologies continue to emerge.
The presentation sparked thoughtful discussion among delegates and emphasised the importance of robust clinical evidence when adopting new therapies into routine practice.
The involvement of our consultants at EAU 2026 reflects the breadth of expertise within our department—from award‑winning patient impact and live surgical teaching to authoritative academic leadership. Most importantly, it reinforces our shared mission: to translate innovation and evidence into better care for patients.
We congratulate Neil Barber, Amr Emara, and Richard Hindley on their exceptional contributions and thank them for representing our organisation with such distinction on the global stage.
An enlarged prostate doesn't just affect older men. This patient story shares the experience of a much younger man who has found having the iTIND procedure life changing for him and urges patients to not ignore symptoms and put up with them. Neil Barber comments in this article from The Sun on the impact the procedure can have and how this relatively new treatment can help younger patients.
